We are a geographically diversified and vertically integrated cannabis group that operates within Health Canada’s Access to Cannabis for Medical Purposes Regulations and distributes globally.
We don’t strive to follow best practices; we aspire to set them by building industry leading companies that transform the perception of cannabis and responsibly elevate the consumer experience.
Our goal is to establish the most valuable international cannabis community comprised of passionate, daring people, driven by quality and integrity, who are determined to write history, not read about it.
We never lose sight of our consumer’s trust as a measure of our success, building an iconic portfolio that offers the most enjoyable products on the market while generating value for our shareholders.
Why we do it
We are driven to create change that removes the misconceptions about cannabis, and we are relentless in our effort to help our patients by providing the best quality products on the market. We take pride in leading the industry forward responsibly and are motivated to create meaningful products that excite our consumers and bring happiness to their lives. Doing what we love and loving what we do, we transform what was once just an idea into reality while appreciating the people that make it possible along the way.
Who we are
The talented management team at Cronos Group Inc.
Michael Gorenstein | President, CEO & Chairman
Before joining Cronos, Mr. Gorenstein was a partner at Alphabet Ventures LLC, a multi-strategy investment management firm located in New York City. Prior to Alphabet Management, Michael was the VP and General Counsel of Saiers Capital LLC and a corporate attorney at Sullivan & Cromwell where he focused on Mergers and Acquisitions and Capital Market transactions. Michael graduated from the University of Pennsylvania Law School with a JD, the Wharton School at University of Pennsylvania with a certificate in BEPP and the Kelley School of Business at Indiana University with a BSB in Finance.
David Hsu | Chief Operating Officer
Prior to joining Cronos, Hsu spent over 10 years with Deloitte/CRG Partners, a premier turnaround consulting firm where he operated and managed distressed companies with revenues in excess of $500M+. His expertise includes financial and operational restructuring, growth creation, and lean manufacturing gleaned from experience working in various sectors including consumer packaged goods, manufacturing, distribution, media, and transportation. Hsu graduated from Babson College with a Bachelor of Science in Business Management and is a certified Lean Six Sigma Black Belt.
William Hilson | Chief Financial Officer
Mr. Hilson is a Certified Public Accountant (CPA) and has spent over 15 years as regional CFO for two publicly listed multinational pharmaceutical companies – Merck KGaA and Serono S.A. His expertise includes financial operations, strategy, performance management, sales & marketing, clinical trial management, international tax, debt & equity financing; including a NASDAQ initial public offering.
Prior to joining Cronos Group, William was also involved in a number of mergers & acquisitions and licensing deals in the pharmaceutical sector. He earned his CPA designation while working at a Toronto firm specializing in tax structure. He graduated from the University of Toronto and The University of Western Ontario where he earned a Master of Science degree in Clinical Biochemistry and an Honours Bachelor of Genetics. An accomplished researcher at the Hospital For Sick Children, William has published abstracts and peer reviewed papers in international journals. William also holds an Audit Committee Board Member designation from The Directors College, McMaster University.
Jason Adler | Director
Jason is the CEO and Managing Member of Alphabet Ventures, LLC, a captive investment vehicle operating in a wide range of domains including growth equity, established companies with growth perspective, and creative debt vehicles. Prior to Alphabet Ventures Jason was the co-founder and CEO of Alphabet Management, LLC, a New York based volatility fund, that focused on identifying mispriced assets across various industries, asset classes and geographies. Jason also founded Geronimo, LLC, an AMEX member broker dealer that made markets in equity options, and he began his career as a market maker at G&D Trading, an AMEX member market maker. Jason received his B.A. from the University of Rhode Island.
Michael Krestell | Director
Mr. Krestell has been the President of M Partners Inc. since 2013 and prior thereto he was the firm’s Managing Director of Equity Research. Mr. Krestell received a Starmine award by being the number 4 ranked stock picker in Canada in 2009. He received an MBA with distinction from the Schulich School of Business and is a CFA charterholder.
Alan Friedman | Director
Mr. Friedman is an attorney and has played an integral role in the establishment, acquisitions, financings and go-public transactions for many Canadian companies. He is co-founder and Director of TSX-V listed companies, Adira Energy Ltd. and Eco (Atlantic) Oil and Gas Ltd. He was also co-founder of Auryx Gold Corp. a TSX listed gold company sold to B2 Gold Corp for $150mm in 2012. He is also CEO of Rivonia Capital, a Canadian boutique finance and facilitation company specializing in public market transactions.
The Cronos Group seeks to fortify and accelerate growth of the most advanced network of medicinal marijuana companies in Canada and has investments in 5 different Licensed Producers.
Cronos Group owns 100% of Peace Naturals, a company licensed to produce and sell medical marijuana as well as cultivate cannabis oil, acting under the authority of a license issued by Health Canada pursuant to the Access to Cannabis for Medical Purposes Regulation (ACMPR). Located in Simcoe County, Ontario, Peace Naturals has 95 acres of land.
Cronos Group owns 100% of Original BC (OGBC), a company that is currently licensed to cultivate and sell medical marijuana, acting under the authority of a license issued by Health Canada pursuant to the Access to Cannabis for Medical Purposes Regulation (ACMPR). OGBC is located on 31 acres of land in the heart of the Okanagan Valley, British Columbia.
Cronos Group owns an interest in Whistler Medical Marijuana Company (WMMC), a company licensed to produce and sell medical marijuana as well as cultivate cannabis oil, acting under the authority of a license issued by Health Canada pursuant to the Access to Cannabis for Medical Purposes Regulation (ACMPR). WMMC is certified organic by the Fraser Valley Organic Producers Association.
Cronos Group owns an interest in ABcann, a company licensed to produce medical marijuana, acting under the authority of a license issued by Health Canada pursuant to the Access to Cannabis for Medical Purposes Regulation (ACMPR). Located in Napanee, Ontario, ABcann has built their processes and company on a commitment to delivering products that are reliable, standardized, repeatable and accessible to everyone.
Cronos Group owns an interest in Hydropothecary, a company licensed to produce medical marijuana, acting under the authority of a license issued by Health Canada pursuant to the Access to Cannabis for Medical Purposes Regulation (ACMPR). Located near Gatineau, Quebec, Hydropothecary has approximately 80 acres of land.
Cronos Group has an arrangement to acquire interest in Evergreen Medicinal Supply, an Access to Cannabis for Medical Purposes Regulation (ACMPR) applicant. Evergreen Medicinal Supply is located near Victoria, British Columbia and has 2.5 acres of land.
Interested in learning more about Cronos Group?
Cronos Group Inc.
76 Stafford Street, Suite 302
Toronto, Ontario M6J 2S1
Send Us a Message
76 Stafford Street, Suite 302
Toronto, Ontario M6J 2S1